RPSA
Richard P. Slaughter Associates’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,327
| Closed | -$325K | – | 116 |
|
|
2025
Q1 | $325K | Sell |
5,327
-29,570
| -85% | -$1.8M | 0.08% | 100 |
|
|
2024
Q4 | $1.97M | Sell |
34,897
-1,804
| -5% | -$102K | 0.44% | 58 |
|
|
2024
Q3 | $1.9M | Buy |
36,701
+2,137
| +6% | +$111K | 0.44% | 61 |
|
|
2024
Q2 | $1.44M | Buy |
34,564
+4,047
| +13% | +$168K | 0.34% | 81 |
|
|
2024
Q1 | $1.65M | Buy |
30,517
+1,102
| +4% | +$59.8K | 0.4% | 67 |
|
|
2023
Q4 | $1.51M | Buy |
29,415
+3,000
| +11% | +$154K | 0.37% | 80 |
|
|
2023
Q3 | $1.53M | Buy |
26,415
+4,375
| +20% | +$254K | 0.41% | 69 |
|
|
2023
Q2 | $1.41M | Buy |
22,040
+750
| +4% | +$48K | 0.4% | 73 |
|
|
2023
Q1 | $1.48M | Buy |
21,290
+1,695
| +9% | +$117K | 0.48% | 62 |
|
|
2022
Q4 | $1.41M | Buy |
19,595
+612
| +3% | +$44K | 0.44% | 68 |
|
|
2022
Q3 | $1.35M | Buy |
18,983
+16,363
| +625% | +$1.16M | 0.56% | 59 |
|
|
2022
Q2 | $201K | Buy |
+2,620
| New | +$201K | 0.09% | 121 |
|